Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Libbey Turns To Profit In Q1

RELATED NEWS
Trade LBY now with 

Libbey Inc. (LBY: Quote) reported first-quarter net income of $0.6 million or $0.03 per share, compared to a net loss of $1.0 million or $0.05 per share last year.

Net sales for the quarter rose to $187.8 million from $181.0 million a year ago.

The company also announced that its subsidiary, Libbey Glass Inc., plans to call for redemption of an aggregate principal amount of $40.0 million of its outstanding 10.0 percent senior secured notes due 2015 prior to the second quarter.

The company plans to fund this redemption using cash on its balance sheet and/or borrowings under its Asset Backed Loan credit facility. This redemption is expected to result in a one-time charge of $2.2 million or about $0.10 per share in the second quarter for early extinguishment of debt.

Click here to receive FREE breaking news email alerts for Libbey Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks saw some volatility following the release of the Federal Reserve's monetary policy announcement on Wednesday but managed to end the day modestly higher. With the upward move, the Dow reached a new record closing high. President Barack Obama sought to emphasize in remarks on Wednesday that the American forces being deployed as part of the fight against the terrorist group ISIS will not have a combat mission. Republican Joni Ernst has moved into the lead in the potentially crucial Iowa Senate race, according to the results of a Quinnipiac University poll released on Wednesday. The poll found that 50 percent of likely Iowa voters would support Ernst if the election were held today, while 44 percent would vote for Democratic Rep. Bruce Braley.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.